tirzepatide b3 Does Adding Vitamin B to Formulations Make Them FDA-Compliant? Tirzepatide B3 plan confusion after

This study aimed to investigate the association between early, short-term adjunctive semaglutide therapy and postoperative weight-loss outcomes after laparoscopic sleeve gastrectomy (LSG) in patients with class II-III obesity

Three new #GLP-1 drugs for obesity treatment2 injectables and 1 pillmay receive FDA approval this year

Lower back pain is not a recognized adverse effect of tirzepatide based on extensive clinical trial data and current guidelines

A new study once again suggests something far more profound than eating less.

GLP-1 receptor agonists can be initiated in patients with sarcopenia when clinically indicated for obesity, type 2 diabetes, or cardiovascular disease, but r...

In mouse studies, boosting BCL6 reversed muscle weakness and shrinkage, hinting at a future where weight-loss shots could be paired with a muscle-preserving therapy.